108945-35-3
Chemical Structure
Taprostene
Synonym(s): CG-4203
- CAS. Nr.: 108945-35-3
- Formula:C24H30O5
- Molecular Weight:398.49
IUPAC Name: 3-((Z)-((3aR,4R,5R,6aS)-4-((S,E)-3-cyclohexyl-3-hydroxyprop-1-en-1-yl)-5-hydroxyhexahydro-2H-cyclopenta[b]furan-2-ylidene)methyl)benzoic acid
InChIKey: ZLJOKYGJNOQXDP-OZUBPDBUSA-N
SMILES: O[C@@H](C1CCCCC1)/C=C/[C@@H]2[C@]3([H])[C@@](C[C@H]2O)([H])O/C(C3)=C\C4=CC(C(O)=O)=CC=C4
Biological Activity: Taprostene (CG-4203) is a synthetic, chemically stable analogue of Prostacyclin (PGI2). Taprostene exhibits endothelium and myocardial protecting actions after acute myocardial ischemia and reperfusion in cats. Taprostene enhances cytoprotective actions, while minimizing unwanted hemodynamic effects[1].
| Art. -Nr. | Produktname | Reinheit | Beschreibung | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Taprostene | Taprostene (CG-4203) is a synthetic, chemically stable analogue of Prostacyclin (PGI2). Taprostene exhibits endothelium and myocardial protecting actions after acute myocardial ischemia and reperfusion in cats. Taprostene enhances cytoprotective actions, while minimizing unwanted hemodynamic effects. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
